Ophthotech (OPHT) announced a strategic review this morning The review is great if you're a member of the management team or a believer that the management team has significant skill in identifying unique compounds; for everyone else, not so much. The current plans probably call for a capital raise or partner in a few years, […]
Ophthotech (OPHT) announced a strategic review this morning The review is great if you're a member of the management team or a believer that the management team has significant skill in identifying unique compounds; for everyone else, not so much. The current plans probably call for a capital raise or partner in a few years, […]
This week, the blog’s focusing on companies trading below net cash value. Net cash investing sounds boring and safe, but I’ve generally found it to be highly volatile. Ophthotech (OPHT) trades below net cash; the question is what management is going to do with the money. Last week, the blog’s focus was on companies with […]
This week, the blog’s focusing on companies trading below net cash value. Net cash investing sounds boring and safe, but I’ve generally found it to be highly volatile. Ophthotech (OPHT) trades below net cash; the question is what management is going to do with the money. Last week, the blog’s focus was on companies with […]
Join the Mailing List
Enter your email address to subscribe to this blog and receive notifications of new posts by email.
